Novel suprasternal Doppler
Research type
Research Study
Full title
Evaluation of a novel suprasternal Doppler probe for hemodynamic assessment in the critically ill
IRAS ID
328073
Contact name
David Brealey
Contact email
Sponsor organisation
Deltex Medical Limited
Duration of Study in the UK
1 years, 4 months, 31 days
Research summary
Critically ill patients often suffer from functional impairment of their cardiovascular system and circulation which can lead to inadequate tissue perfusion and organ dysfunction. While lack of treatment of such a condition is associated with high morbidity and mortality, the clinical assessment of cardiovascular impairment by hospital staff has been proven to be very difficult. Therefore, to aid physicians in their decision-making and to avoid therapeutic mismanagement in a highly vulnerable patient population, objective measurements by devices capable of hemodynamic monitoring are necessary. This additional data will guide management and aid the clinician in making informed, appropriate decisions. More sophisticated monitoring technology however requires a more invasive approach or specialized skills that are not generally available to non-critical care areas. It is therefore our objective to assess a novel non-invasive suprasternal (the notch above the breastbone) Doppler hemodynamic monitoring device. We will investigate the performance of this novel device and compare it to existing monitoring devices such as the oesophageal Doppler. This study will be the first clinical evaluation of a novel non-invasive suprasternal Doppler probe for hemodynamic assessment in both high-risk and critically ill patients. This study will assess the validity and utility of this approach which has immediate application to the management of patients also in non-critical care areas that can extend from general wards and the emergency department to out-of-hospital ‘field’ assessments.
REC name
London - Brighton & Sussex Research Ethics Committee
REC reference
23/LO/0583
Date of REC Opinion
16 Aug 2023
REC opinion
Further Information Favourable Opinion